Pathways
cMET
CKIT
Akt
ALK
PRLR
JAK/STAT
RTK
CD19
FGFR
HSP
DAC
IAP
HED
WNT
GPCR
GPCR
HDM2
AND
AND
FGFR
cMet
FLT 3
ckit
SMO
RAF
P13K
MEK
ALK
PKC
PKC
CDK
mTOR
PRLR
JAK2
JAK2
JAK2
JAK2
PIM2
JAK2
DKK1
XIAP
DAC
DAC
P13K

Last updated on Dec, 2016.

All Compounds are either investigational or studied in new indications. Efficacy and safety have not been established. There is no guarantee that they will become commercially available.

The search results, details, and descriptions of clinical trials viewed herein are supplied by ClinicalTrials.gov and EUtrialregistry.com. This information is maintained by a third party over whom Novartis Pharmaceuticals Corporation has no control. As such, Novartis Pharmaceuticals Corporation does not guarantee the accuracy, completeness, adequacy, or any other aspect of the information contained on this site.